Get the Stockscreener App
344.06
1.94%
-6.82
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $344.06, with a volume of 355.90K.
It is down -1.94% in the last 24 hours and up +2.24% over the past month.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
See More
Previous Close:
$350.88
Open:
$353.31
24h Volume:
355.90K
Relative Volume:
0.67
Market Cap:
$20.85B
Revenue:
$2.91B
Net Income/Loss:
$622.64M
P/E Ratio:
32.83
EPS:
10.48
Net Cash Flow:
$620.14M
1W Performance:
-1.82%
1M Performance:
+2.24%
6M Performance:
-10.52%
1Y Performance:
+2.27%
1-Day Range:
$343.15
$356.48
1-Week Range:
$328.79
$358.37
52-Week Range:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
344.06 | 20.85B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Analyst Expectations For Waters's Future - Benzinga
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT Stock News - GuruFocus
UBS Lowers Price Target for Waters (WAT) to $360 | WAT Stock New - GuruFocus
UBS Adjusts Price Target for Waters (WAT) Following Strong Quarter | WAT Stock News - GuruFocus
Waters Corporation (NYSE:WAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Analyst Boosts Price Target for Waters (WAT) Following Strong Q1 Results | WAT Stock News - GuruFocus
Barclays Adjusts Price Target for Waters (WAT) Following Q1 Results | WAT Stock News - GuruFocus
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instrument Sales and Raised Guidance ... - Yahoo Finance
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instr - GuruFocus
Waters Corporation Reports Strong Q1 2025 Results - TipRanks
Decoding Waters Corp (WAT): A Strategic SWOT Insight - GuruFocus
Waters: Q1 Earnings Snapshot - CTPost
Waters Corp Earnings Call: Strong Growth Amid Challenges - TipRanks
Waters Corporation: Still A Hold After Q1 Earnings (NYSE:WAT) - Seeking Alpha
Waters Earnings: Fair Value Estimate Up Amid Strong Start to 2025, Including Higher Instrument Sales - Morningstar
Waters Is Recovering Following a Post-Pandemic Reset Period - Morningstar
Waters (WAT) Exceeds Q1 Revenue Forecasts with Strong Performanc - GuruFocus
Waters Corp. (WAT) Anticipates Strong Sales Growth in Q2 2025 | - GuruFocus
Waters Corp Lifts Profit Forecast After Strong Demand In Asia And Americas - Finimize
Waters Corp (WAT) Q1 2025 Earnings: Revenue Surpasses Estimates at $662M, GAAP EPS Slightly Misses at $2.03 - GuruFocus
Waters Breakthrough: 6-Month Validation Time Savings for Biopharma Quality Control Testing - Stock Titan
Waters Corp. Q1 Profit Increases, Beats Estimates - Nasdaq
What To Expect From Waters Corporation’s (WAT) Q1 Earnings - Yahoo Finance
Assessing Risky S&P 500 Stocks: EPAM, HPE, and Waters CorpNews and Statistics - IndexBox
Waters Corp (WAT) Stock Price Up 4.63% on Apr 22 - GuruFocus
Is There An Opportunity With Waters Corporation's (NYSE:WAT) 25% Undervaluation? - Yahoo Finance
Waters (WAT) Sees Price Target Reduction by Baird Ahead of Q1 Results | WAT Stock News - GuruFocus
Chromatography Market to Reach $14.37 Billion, Globally, by 2032 at 5.3% CAGR: Coherent Market Insights - GlobeNewswire Inc.
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
Waters Corp (WAT) Faces Lowered Price Target Amid Industry Conce - GuruFocus
Waters Corp (WAT) Faces Lowered Price Target Amid Industry Concerns | WAT Stock News - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corporation Q1 Earnings: Global Analytics Leader Sets Key Investor Date - Stock Titan
Option oneJoint waters company with Waikato District Council - Hamilton City Council
Waters expands Alliance iS Bio HPLC product line with Photodiode Array Detector for biopharma development & QC - SelectScience
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit - ET HealthWorld
Waters (NYSE:WAT) Expands Bio HPLC Line With PDA Detection Enhancing Lab Efficiency - Yahoo Finance
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC – Company AnnouncementFT.com - Financial Times
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC - PR Newswire
KeyBanc raises Waters Corp. stock rating to Overweight By Investing.com - Investing.com Canada
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom By Investing.com - Investing.com South Africa
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
KeyBanc raises Waters Corp. stock rating to Overweight - Investing.com
Waters Corporation (NYSE:WAT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance
AppLovin shares plunge 20% after third short-selling firm slams company's ad technology - CNBC
AppLovin Shares Sink After Muddy Waters Issues Short Report - Bloomberg.com
Expert Outlook: Waters Through The Eyes Of 7 Analysts - Benzinga
Waters Corporation Stock: Is WAT Outperforming the Healthcare Sector? - Nasdaq
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Waters Corporation Stock: Is WAT Outperforming The Healthcare Sector? - Barchart
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):